期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Objective: To compare the clinical outcomes of patients with active immunoglobulin G (IgG) 4 related disease (IgG4-RD) receiving tocilizumab versus th......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Aims: In this study, we aimed to decipher the impact of enhancer of zeste homolog 2 (EZH2) in psoriasis as well as the underlying mechanism. Methods: ......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Aim: To compare the outcomes between the arthroscopic debridement of the extensor carpi radialis brevis (ECRB) tendon alone and repairs to the ECRB te......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background: To investigate the efficacy and safety of biologics in the perioperative management of severe aortic valve regurgitation (AR) caused by Be......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Aims: Acute myeloid leukemia (AML) is an aggressive hematologic neoplasm, in which relapse due to drug resistance is the main cause for treatment fail......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Purpose: To explore the impact of coronavirus disease 2019 (COVID-19) on the prognosis of patients with neovascular age-related macular degeneration (......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Autoimmune liver disease (AILD) is a series of chronic liver diseases with abnormal immune responses, including autoimmune hepatitis (AIH), primary bi......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background and Aims: Studies have shown that dipeptidyl peptidase-4 (DDP-4) inhibitors have anti-atherosclerotic effects. However, in the PROLOGUE stu......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background: The consistency in steatosis grading between magnetic resonance imaging-based proton density fat fraction (MRI-PDFF) and controlled attenu......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background: Low muscle mass and osteoporosis are commonly observed in individuals with type 2 diabetes mellitus (T2DM). We investigated the prevalence......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Aims: This study aimed to explore the effects of vertebral rotation on the position of the aorta relative to the thracolumbar and lumbar spine, and to......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background and Aims: Whether non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident chronic kidney disease (CKD) i......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background: Coronary artery disease (CAD) is the leading cause of death in advanced kidney disease. However, its best treatment has not been determine......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background: Studies regarding the relationship of sclerostin (Scl) with clinical outcomes in patients undergoing maintenance haemodialysis have yielde......
期刊： THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021; 12 ()
Background: Accumulating evidence has demonstrated that bone marrow mesenchymal stem cells (BMSCs)-derived extracellular vesicles (EVs) can be used ef......
